These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6720266)

  • 1. Retinal vein occlusion: C-reactive protein and arterial hypertension.
    Dodson PM; Shine B
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):123-30. PubMed ID: 6720266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal vein occlusion and the prevalence of lipoprotein abnormalities.
    Dodson PM; Galton DJ; Hamilton AM; Blach RK
    Br J Ophthalmol; 1982 Mar; 66(3):161-4. PubMed ID: 7066266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-thromboglobulin and platelet factor 4 levels in retinal vein occlusion.
    Dodson PM; Westwick J; Marks G; Kakkar VV; Galton DJ
    Br J Ophthalmol; 1983 Mar; 67(3):143-6. PubMed ID: 6186271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion.
    Trope GE; Lowe GD; McArdle BM; Douglas JT; Forbes CD; Prentice CM; Foulds WS
    Br J Ophthalmol; 1983 Mar; 67(3):137-42. PubMed ID: 6824618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic diseases associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman B; McCarthy MJ; Podhajsky P
    Am J Ophthalmol; 2001 Jan; 131(1):61-77. PubMed ID: 11162981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical conditions underlying recurrence of retinal vein occlusion.
    Dodson PM; Kubicki AJ; Taylor KG; Kritzinger EE
    Br J Ophthalmol; 1985 Jul; 69(7):493-6. PubMed ID: 4016042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions.
    Appiah AP; Trempe CL
    Ophthalmology; 1989 Mar; 96(3):364-6. PubMed ID: 2710528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viscosity and retinal vein thrombosis.
    Ring CP; Pearson TC; Sanders MD; Wetherley-Mein G
    Br J Ophthalmol; 1976 Jun; 60(6):397-410. PubMed ID: 952813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance.
    Costenbader KH; Chibnik LB; Schur PH
    Clin Exp Rheumatol; 2007; 25(5):746-9. PubMed ID: 18078625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
    J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equivalence of the acute phase reactants C-reactive protein, plasma viscosity, and Westergren erythrocyte sedimentation rate when used to calculate American College of Rheumatology 20% improvement criteria or the Disease Activity Score in patients with early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
    Paulus HE; Ramos B; Wong WK; Ahmed A; Bulpitt K; Park G; Sterz M; Clements P
    J Rheumatol; 1999 Nov; 26(11):2324-31. PubMed ID: 10555885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal blood rheology in retinal vein occlusion. A preliminary report.
    Peduzzi M; Debbia A; Guerrieri F; Bolzani R
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(1):83-5. PubMed ID: 3943743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of erythrocyte sedimentation rate and C-reactive protein in patients with active uveitis.
    Groen-Hakan F; Eurelings L; van Laar J; Rothova A
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):175-180. PubMed ID: 30411142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Branch retinal vein occlusion: the pathogenetic role of blood viscosity.
    Piermarocchi S; Segato T; Bertoja H; Midena E; Zucchetto M; Girolami A; Procidano M; Mares M
    Ann Ophthalmol; 1990 Aug; 22(8):303-11. PubMed ID: 2221710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure in retinal vein occlusion.
    Frucht J; Shapiro A; Merin S
    Br J Ophthalmol; 1984 Jan; 68(1):26-8. PubMed ID: 6689932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with branch vs. central retinal vein occlusion.
    Appiah AP; Trempe CL
    Ann Ophthalmol; 1989 Apr; 21(4):153-5, 157. PubMed ID: 2729819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemorheological changes in patients with retinal vein occlusion after isovolaemic haemodilution.
    Wiek J; Schade M; Wiederholt M; Arntz HR; Hansen LL
    Br J Ophthalmol; 1990 Nov; 74(11):665-9. PubMed ID: 2223704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma pentraxin 3 and its association with retinal vein occlusion.
    Park KS; Kim JW; An JH; Woo JM
    Korean J Ophthalmol; 2014 Dec; 28(6):460-5. PubMed ID: 25435748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.